GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Syros Pharmaceuticals SYRS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Syros Pharmaceuticals

Our reporting

We have not reported on Syros Pharmaceuticals yet.

Next results

31 Mar 2027

Due on 31 Mar 2027. Analysts expect earnings of -4.38 a share on revenue of $4.5m.

Past results

Reported against what analysts expected

26 Mar 202531 Oct 202431 Jul 202413 May 202427 Mar 202414 Nov 2023
Earnings per share-1.19-0.16-0.70-0.10-2.18-1.35
Forecast-0.70-0.76-0.79-0.89-1.14-1.12
Revenue————$387,000$3.8m
Forecast—$360,000$460,000$720,000$2.0m$2.0m

Key events

  1. 19 Sept 202210-to-1 reverse split
  2. 30 Jun 2016Listed

Syros Pharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.